scholarly journals Effect of Psychological Nursing on the Mental State and Quality of Life of Patients After Heart Valve Replacement for Rheumatic Heart Disease

2021 ◽  
Vol 5 (5) ◽  
pp. 142-146
Author(s):  
Lijuan Wu ◽  
Liping Feng ◽  
Hui Chen

Objective: To explore the effect of psychological nursing on the mental state and quality of life of patients after heart valve replacement for rheumatic heart disease. Methods: Seventy-four patients with rheumatic heart disease that underwent heart valve replacement in Zhenjiang First People’s Hospital from January 2017 to May 2020 were selected as the research subjects. Thirty-seven patients that were treated from January 2017 to September 2018 were included in the control group. Routine care was provided for the patients in the control group. From October 2018 to May 2020, the Department of Cardiothoracic Surgery improved their preoperative and postoperative psychological care. Thirty-seven patients that were treated during this period were included in the research group. The research group received psychological nursing care in addition to routine care. The effects of different nursing modes on the quality of life and postoperative mental state of the patients were determined. Results: The scores for depression, anxiety, somatization, and compulsion in the research group were significantly lower than those in the control group (p < 0.05); the scores for the quality of life of patients in the research group were significantly higher than those in the control group (p < 0.05). Conclusions: Strengthening psychological nursing for patients with rheumatic heart disease is helpful to improve their quality of life and mental state after heart valve replacement.

Author(s):  
Grisha Ratnani ◽  
Rashmi Walke ◽  
Moli Jai Jain ◽  
Vishnu Vardhan ◽  
Vaishnavi Yadav ◽  
...  

Rheumatic heart disease is one of the principal contributors that has a negative influence on a patient's quality of life and makes it challenging for them to perform their daily activities. The disorder predominantly impairs the function of heart valves, specifically the mitral valve, resulting in stenosis that can be managed by repair or replacement of the valve. The purpose of treatment is to improve the patient's quality of life. As an adjunct to that, cardiac rehabilitation and exercise therapy are used. This case study discusses a patient with mitral stenosis and mitral regurgitation, who underwent mitral valve replacement. She was given with physiotherapy for a week of phase I cardiac rehabilitation and was prescribed home exercise.


Author(s):  
Leksha Atul Patel ◽  
Vaishnavi Dilip Yadav ◽  
Moli Jai Jain ◽  
Om C. Wadhokar

Heart disease due to valvular anomaly has increased prevalence along with increasing age. Rheumatic heart disease is a condition in which the heart valves have been permanently damaged post rheumatic fever. The operative management including reparation or substitution with prosthetic valve is the main therapy. Still becoming question mark either rehabilitation program is beneficence for the patient undergoing valvular surgery. We report a patient with severe mitral valve regurgitation, moderate mitral stenosis, moderate tricuspid regurgitation, and severe pulmonary artery hypertension secondary to Rheumatic Heart Disease. He underwent Mitral valve replacement surgery and advised post-operative physiotherapy which comprises 2 weeks of phase I cardiac rehabilitation, a home exercise program after discharge, and follow-up after 2 weeks. During follow up patient has a high level of independence, improvement in quality of life, and early return to work.


2016 ◽  
Vol 175 ◽  
pp. 123-129 ◽  
Author(s):  
Tyler Bradley-Hewitt ◽  
Andrea Dantin ◽  
Michelle Ploutz ◽  
Twalib Aliku ◽  
Peter Lwabi ◽  
...  

2019 ◽  
Vol 35 (4) ◽  
Author(s):  
Kebiao Chen ◽  
Li Qin ◽  
Xin Lu ◽  
Tao Xia ◽  
Qing Gu

Objectives: To explore the efficacy of amiodarone in the treatment of atrial fibrillation for patients with rheumatic heart disease after valve replacement. Methods: Eighty-six patients with rheumatic heart disease who were hospitalized between June 2016 and June 2017 and developed atrial fibrillation after valvular heart valve replacement were randomly divided into a control group and an observation group, 42 cases in each group. The control group was treated with routine medical treatment, while the observation group was given amiodarone on the basis of routine treatment. The cardiac function of the two groups were observed and recorded. Postoperative atrial fibrillation conversion rate, sinus rhythm maintenance rate, intensive care unit (ICU) monitoring time and hospital stay were compared between the two groups. Results: Compared with the control group, the improvement of cardiac function indexes of the observation group was better, and the difference was statistically significant (P<0.05). The atrial fibrillation conversion rate and the maintenance rate of sinus rhythm of the observation group were 76.2% and 47.6% respectively, which were significantly higher than 57.1% and 33.3% of the control group; the differences had statistical significance (P<0.05). The ICU monitoring time and hospitalization time of the patients in the observation group were (1.69±0.91) d and (10.24±1.11) d respectively, which were significantly shorter than (2.83±0.95) d and (14.07±1.17) d in the control group (P<0.05); the differences were statistically significant (P<0.05). Conclusion: Amiodarone can effectively treat valve replacement associated atrial fibrillation of patients with rheumatic heart disease. It can significantly improve the heart function, prevent the recurrence of atrial fibrillation, maintain sinus rhythm after operation, and shorten the time of ICU monitoring and hospitalization. doi: https://doi.org/10.12669/pjms.35.4.1298 How to cite this:Chen K, Qin L, Lu X, Xia T, Gu Q. Amiodarone in the treatment of atrial fibrillation of patients with rheumatic heart disease after valve replacement. Pak J Med Sci. 2019;35(4):---------. doi: https://doi.org/10.12669/pjms.35.4.1298 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


2020 ◽  
Vol 13 (8) ◽  
pp. 3792
Author(s):  
Sabreena S Sheikh ◽  
Anwar H Ansari ◽  
Manoj K Mudigubba ◽  
Saurabh Dahiya

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Dan Li ◽  
Pujuan Liu ◽  
Huijun Zhang ◽  
Li Wang

Abstract Background To observe the effect of phased written health education combined with healthy diet on the quality of life of patients after heart valve replacement. Methods One hundred-thirty patients who underwent heart valve replacement surgery in our hospital from January 2018 to January 2020 were enrolled as the research subjects. They were randomly divided into study group (65 patients, phased written health education combined with health Diet) and control group (65 cases, routine health education). The drug compliance and the degree of anticoagulant drugs knowledge were compared between the two groups in the first and second stage rehabilitation and the recovery stage. The health behavior ability and quality of life at different phases were also observed. Results During the first and the second stage rehabilitation, and the recovery stage, the drug compliance of the study group was superior to that of the control group, with statistical significance (P < 0.05). Meanwhile, the knowledge of anticoagulant drugs in the study group was better than that in the control group, with statistical significance (P < 0.05). Before intervention, there was no significant difference in health behavior ability and quality of life between the two groups (P > 0.05). The healthy behavior ability of study group for each stage was superior to the control group, the difference was significant (P < 0.05). The healthy behavior ability and quality of life showed the same results with statistical significance (P < 0.05). Conclusion The use of phased written health education combined with healthy diet in patients after heart valve replacement can effectively improve patients’ medication compliance, anticoagulant drugs knowledge, healthy behavior ability and quality of life at different stages, and is worthy of clinical application.


2020 ◽  
Vol 6 (2) ◽  
pp. 78
Author(s):  
I Gusti Ayu Trisna Windiani ◽  
Putu Diah Vedaswari ◽  
Eka Gunawijaya ◽  
Ni Putu Veny Kartika Yantie ◽  
I Gusti Agung Ngurah Sugitha Adnyana ◽  
...  

PLoS ONE ◽  
2021 ◽  
Vol 16 (10) ◽  
pp. e0259340
Author(s):  
Jyoti Dixit ◽  
Gaurav Jyani ◽  
Shankar Prinja ◽  
Yashpaul Sharma

Background Measurement of health-related quality of life (HRQOL) of people with chronic illnesses has become extremely important as the mortality rates associated with such illnesses have decreased and survival rates have increased. Thereby, such measurements not only provide insights into physical, mental and social dimensions of patient’s health, but also allow monitoring of the results of interventions, complementing the traditional methods based on morbidity and mortality. Objective The present study was conducted to describe the HRQOL of patients suffering from Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD), and to identify socio-demographic and clinical factors as predictors of HRQOL. Methodology A cross-sectional study was conducted to assess the HRQOL among 702 RF and RHD patients using EuroQol 5-dimensions 5-levels instrument (EQ-5D-5L), EuroQol Visual Analogue Scale and Time Trade off method. Mean EQ-5D-5L quality of life scores were calculated using EQ5D index value calculator across different stages of RF and RHD. Proportions of patients reporting problems in different attributes of EQ-5D-5L were calculated. The impact of socio-economic determinants on HRQOL was assessed. Results The mean EQ-5D-5L utility scores among RF, RHD and RHD with Congestive heart failure patients (CHF) were estimated as 0.952 [95% Confidence Interval (CI): 0.929–0.975], 0.820 [95% CI: 0.799–0.842] and 0.800 [95% CI: 0.772–0.829] respectively. The most frequently reported problem among RF/RHD patients was pain/discomfort (33.8%) followed by difficulty in performing usual activities (23.9%) patients, mobility (22.7%) and anxiety/depression (22%). Patients with an annual income of less than 50,000 Indian National Rupees (INR) reported the highest EQ-5D-5L score of 0.872, followed by those in the income group of more than INR 200,000 (0.835), INR 50,000–100,000 (0.832) and INR 100,000–200,000 (0.828). Better HRQOL was reported by RHD patients (including RHD with CHF) who underwent balloon valvotomy (0.806) as compared to valve replacement surgery (0.645). Conclusion RF and RHD significantly impact the HRQOL of patients. Interventions aiming to improve HRQOL of RF/RHD patients should focus upon ameliorating pain and implementation of secondary prevention strategies for reducing the progression from ARF to RHD and prevention of RHD-related complications.


2019 ◽  
Vol 9 (3) ◽  
pp. 222-228
Author(s):  
V. S. Petrov

The objective. The assessment of the severity, prevalence and five-year dynamics of anxiety and depression in those studied with rheumatic heart disease.Materials and methods. The study included 168 patients with rheumatic heart disease: mean age 58,69±0,47 years; 141 women (83,93%) and 27 men (16,07%). To assess anxiety and depression, the following scales were used: HADS (hospital anxiety and depression scale), CES-D (depression scale of the epidemiological research center), and STAI (Spielberger anxiety scale). Quality of life was assessed using total scale SF-36 (Short Form Medical Outcomes Study), KCCQ (Kansas questionnaire for patients with cardiomyopathy), and MHFLQ (Minnesota questionnaire for the quality of life of patients with CHF).Results. Initially, patients with rheumatic heart disease had mild depression and anxiety, except for the high level of state anxiety according to STAI — 48.00 ± 0.95. More pronounced depressive disorders were revealed in patients with CHF NYHA III and IV. According to CES-D — 17,58±1,27 for FC I and 23,4±0,75 for FC IV, for HADS — 7,00±0,64 for FC I and 13,6±0,78 for FC IV. Anxiety disorders, on the contrary, were less with III and IV FC CHF: 8,5±0,49 with FC I and 8,2±1,02 with FC IV in HADS. According to STAI state anxiety — 47,58±1,22 (FC I) and 42,8±1,76 (FC IV), for trait anxiety — 42,67±1,08 (FC I) and 40,4±1,85 (FC IV). For the five-year period there was no negative and positive dynamics according to the questionnaires of anxiety and depression. The only exception was the increase in anxiety according to HADS by 0.66 points. In terms of quality of life, there was a decrease in physical health according to SF-36 by 1.78, and in overall summary score according to KCCQ by 1.55 and MHFLQ by — 3.99.Conclusions. In patients with rheumatic heart disease, the severity of anxiety and depression is insignificant and does not increase during five years of observation. Indicators of depression are more pronounced in the group with CHF NYHA III and IV, and anxiety indicators in patients with CHF NYHA I and II. An increase in depression rates in subjects with rheumatic heart disease is associated with a deterioration in the quality of life. With an improvement in the quality of life values, depressive symptoms decrease, and anxiety rates increase.


Sign in / Sign up

Export Citation Format

Share Document